Table 3.
IDEAL stage | |||||
---|---|---|---|---|---|
Indication | 1 (case report) | 2a (cohort study) | 2b (feasibility RCT) | 3 (RCT) | 4 (registry) |
Total (n = 35) | 0 | 34 | 0 | 1 | 0 |
Prophylaxis (n = 4) | 0 | 3 | 0 | 1 | 0 |
Reinforcement (n = 23) | 0 | 23 | 0 | 0 | 0 |
Mixed (n = 8) | 0 | 8 | 0 | 0 | 0 |